[IEEE TRANSDUCERS 2009 - 2009 International Solid-State Sensors, Actuators and Microsystems...
Transcript of [IEEE TRANSDUCERS 2009 - 2009 International Solid-State Sensors, Actuators and Microsystems...
PROTOTYPE MICRO GAS CHROMATOGRAPH FOR BREATH BIOMARKERS OF RESPIRATORY DISEASE
S. K. Kim1, H. Chang1, and E .T. Zellers1,2*
Center for Wireless Integrated Microsystems (WIMS), Departments of 1Environmental Health Sciences, 2Chemistry, University of Michigan, Ann Arbor, MI, USA
ABSTRACT Progress toward a prototype MEMS gas
chromatograph (μGC) designed for analyzing complex mixtures of volatile organic compounds (VOC) in breath is described. This µGC, named SPIRON, integrates a multi-stage preconcentrator/injector, a dual-microcolumn separation module, and a chemiresistor array detector with commercial minivalves and a minipump. Here, we describe results showing thermal control of all key system components and then present the rapid separation of two complex mixtures: one containing lung cancer biomarkers and the other containing tuberculosis biomarkers, both in backgrounds of 30 common breath VOCs. The fully assembled SPIRON µGC prototype is also presented. KEYWORDS
Lung cancer, tuberculosis, breath biomarker, μGC, micro column, sensor INTRODUCTION
It has long been known that the analysis of breath samples can be used as a non-invasive diagnostic tool for certain diseases [1-3]. Many investigations have focused on lung cancer, because it is the leading cause of cancer death in the U. S. and the five-year survival rate can be 60-80% if the disease is diagnosed at an early stage [4]. Another major lung disease is tuberculosis (TB), which is the foremost cause of death from a single infectious agent in the world, causing more than 26% of avoidable adult deaths in the developing countries [5].
Simple methods for early non-invasive diagnosis of lung cancer, TB and other diseases are needed. The instrument most commonly used for analysis of volatile organic compounds (VOC) in breath is a gas chromatograph coupled with a mass spectrometer detector (GC-MS) because of its versatility for determining a wide range of volatile analytes [6]. Efforts to miniaturize MS and GC-MS systems have been mounted by several groups and organizations [7-10].
In this research, we are developing a micro gas chromatograph (μGC), referred to as SPIRON, and
tailoring its design and operating parameters to the problem of determining biomarkers for lung cancer and TB in breath. The challenge is to differentiate the biomarkers from endogenous and exogenous VOC interferences at low- or sub-parts-per-billion concentrations in a matrix nearly saturated with water vapor. The layout diagram of the analytical subsystem of the SPIRON µGC is shown in Figure 1. It is based on a previous prototype µGC developed in our group [11]. The key components of the instrument are a microfabricated 3-stage preconcentrator/focuser (µPCF), two 3-meter-long DRIE-Si/glass microcolumns with a non-polar PDMS stationary phase coated on the interior walls, and a thermo-electrically cooled chemiresistor (CR) array that uses thiolate-monolayer-protected gold nanoparticle (MPNs) films as the interface layers. Commercial valves are used as well as a commercial miniature rotary-vane pump. The microcolumns are independently temperature-programmable from room temperature to ~200 ºC. The system also uses heated MEMS interconnects. Scrubbed air is used as the carrier gas to avoid the need of cylinder gas. Based on published research and our own GC-MS measurements of breath from healthy subjects and indoor air samples collected from 5 different sites, 7 biomarkers of lung cancer, 6 biomarkers of tuberculosis [1-3], and 30 common interferences have been selected for initial studies. The lung cancer markers are isoprene, pentane, 2-methylpentane, ethylpropanoate, benzene, toluene, and ethylbenzene [1,2]. The markers for pulmonary tuberculosis are 1,4-dimethylcyclohexane, 3-heptanone, 2,2,4,6,6-pentamethylheptane, p-cymene, and 1-methylnaphthalene [3]. The work described here is focused primarily on component-level testing. High-speed separations of lung cancer and TB biomarkers from potential interferences are shown using a conventional flame ionization detector. The use of integrated heaters and software-based controllers for rapid μPCF and microcolumn heating is illustrated, along with rapid changes and in the operating temperature of the
978-1-4244-4193-8/09/$25.00 ©2009 IEEE Transducers 2009, Denver, CO, USA, June 21-25, 2009128
M3P.027
sensor array using a TE cooler. The assembled SPIRON µGC prototype is also presented.
Figure 1. Fluidic layout diagram of the SPIRON system RESULTS AND DISCUSSION Thermal Control of Microsystem Components As shown schematically in Figure 2, a control program written in Labview (National Instruments, Austin, TX) was used with a 16-bit DAQ card to operate all the components and to process the signal readouts from the sensor array. A pulse-width-modulated (PWM) square wave function generated by the DAQ is used to control the rate of heating or cooling for all components. The active time of PWM square wave is calculated by proportional-integral-derivative (PID) algorithm [12].
1stμ
colu
mn
Inter connection
μPCFμTee
To Pump
PCB Carrier Board
2nd μcolumn
CR Sensor Array
Digital Output
Analog-to-Digital
DAQ
8 channels CR amplifier
Pulse Driver
RTD Current source
Optical Relay
Electronic HardwareVal
ve
TE Cooler Driver
RTD
Heater
RTD
Heater
USB interface
Figure 2. SPIRON system electronic hardware including TE cooler driver and electronic connection between PCB carrier board and electronic hardware. A µPCF filled with a graphitized carbon adsorbents was heated by the integrated heater and its temperature was measured by integrated RTD. A programmable DC power supply was used to bias the heater at an initial current limit of 500 mA. After passing the transition temperature of the Si substrate (~200 °C), the resistance dramatically drops from 1400 Ω to 40 Ω and the power supply switched to constant-current mode with a limit of 290 mA. With this controlling method, the temperature of the µPCF rose to 300ºC in 7 s and could be maintained at 300ºC (± 2.2°C) for an extended period of time as shown in Figure 3.
050
100150200250300
0 20 40 60 80
Time(s)
Tem
pera
ture
(oC
)
Figure 3. Temperature profile of the µPCF when applied with DC voltage between integrated heaters. The ability to quickly adjust, and then control, the temperature of the CR array was also explored. A 4 cm2 TE cooler (CUI Inc., Tualatin, Oregon) was attached to the underside of the array along with a brass heat sink and a small fan. As shown in Figure 4(a), the array could be controlled with the TE cooler at 15 ºC, rapidly shifted to 45 ºC in 5 s, and maintained at this temperature. The array was then installed as a detector in a bench scale GC instrument. Figure 4(b) shows the CR sensor signal improvement for injected samples of n-octane when the temperature of the array was cooled down from room temperature to 15 ºC (~22% in peak height and 134% in peak area).
Time(sec)
0 200 400 600 800 1000
Tem
pera
ture
10
15
20
25
30
35
40
45
50
Time(sec)
0 200 400 600 800 1000
Tem
pera
ture
10
15
20
25
30
35
40
45
50
0
5
10
15
20
25
30
35
10 20 30 40 50 60 70 80 90 100
Time (sec)
mV
(1)
(2)
Figure 4(a) Output from the RTD temperature sensor on the surface of the array showing that the CR array temperature can be controlled at 15 oC and rapidly shifted to 45 oC in 5 sec. (b) Responses from a CR sensor with a coating of C8-MPN used as the detector for a bench-scale GC to injections of n-octane at sensor temperatures of (1) 25 oC and (2) 15 oC. A retention time offset was used for the 2nd trace above to facilitate visual comparison of octane peaks.
120 mm
100 mm
2-way valve
3-stage
µtee 1st 3-m
µColumn
2nd 3-m µColumn
8 channel CR sensor
& TE
control cable connector
connect to pump
sample inlet
129
Figures 5 and 6 show the separations of the lung cancer and TB biomarkers from 30 common breath VOC constituents, respectively. For these tests the dual-column ensemble was mounted in the oven of a bench-scale GC, connected to the injector and FID detector, and it was temperature programmed from room temperature to 150°C. The 7 biomarkers of lung cancer are separated in 4 min, even though the remaining compounds require 7.5 min to elute. The 6 TB biomarkers are separated in ~ 8 min. Air was used as a carrier gas. Figure 7 shows response patterns from a CR array for 5 of the 7 lung cancer biomarkers obtained in separate testing (unpublished) with a portable GC using the CR-array detector [13]. Unique response patterns and detection limits in the low-ppb range are achieved for most of the biomarkers by preconcentrating a 1-L sample volume. However, early-eluting biomarker peaks are obscured by the relatively large residual-water peaks even though a short dry-air purge of the preconcentrator was incorporated into the analytical protocol. The chromatogram shown in the lower portion of Figure 7 is from the C8-MPN sensor, which is the least water sensitive sensor. Other sensors in the array give larger water vapor peaks. Use of Nafion tubing at the inlet succeeded in removing a significant fraction of water vapor from the sample, but additional measures are needed to completely resolve this problem.
1 2 3 4 5 6 7 8 0
time (min)
21
3
4
5
6
7
8
9
10
11
12
13
1514
1716
18
19
20
2221
23
24
25
26
2827
3029
31
32
3433
35
36
37
1 2 3 4 5 6 7 8 0
time (min)
21
3
4
5
6
7
8
9
10
11
12
13
1514
1716
18
19
20
2221
23
24
25
26
2827
3029
31
32
3433
35
36
37
1 2 3 4 5 6 7 8 0
time (min)1 2 3 4 5 6 7 8 0
time (min)
21
3
4
5
6
7
8
9
10
11
12
13
1514
1716
18
19
20
2221
23
24
25
26
2827
3029
31
32
3433
35
36
37
Figure 5. Temperature-programmed dual-3-m-microcolumn chromatogram of 7 lung cancer breath biomarkers (boxes) and 30 common breath-VOC interferences.
2 4 6 8 0 1 3 5 7
time (min)
1 2
3
45
76
8
109
11-13
14
15
16
17-19
20
2122
2423
2625
27
28
29
3130
3332
34
35
36
2 4 6 8 0 1 3 5 7
time (min)
1 2
3
45
76
8
109
11-13
14
15
16
17-19
20
2122
2423
2625
27
28
29
3130
3332
34
35
36
Figure 6. Temperature-programmed dual-3-m-microcolumn separation of 6 pulmonary tuberculosis biomarkers (boxes) from 30 common interferences.
(12) TOL (19) EBZ
C8 OPH HME CCNC8 OPH HME CCN
45
201710
water3
67
8 9 11 121314
1516
18
19
21222324
25
26-3132-35
36-371
2
50 100 150 200 50 100 150 200 0Time (s)
(3) 2MPEN
C8 OPH HME CCN
(8) BZ (11) EPRO
C8 OPH HME CCN C8 OPH HME CCN
Figure 7. Normalized response patterns for 5 lung cancer biomarkers obtained by the CR-sensor array from separate tests in a portable GC. The acronyms in the response patterns refer to the structures of the ligands of the MPNs: n-ctanethiolate (C8), 1-mercapto-6-phenoxyhexane (OPH), 7-mercaptoheptanitrile (CCN), and methyl 6-mercaptohxanoate (HME) and the name of compounds: 2-methylpentane (2MPEN), benzene (BZ), ethylpropanoate (EPRO), toluene (TOL), and ethylbenzene (EBZ). Single-sensor (C8) chromatogram trace of lung cancer biomarkers and 30 common VOCs found in normal human breath. System Integration The assembled SPIRON µGC, consisting of a printed-circuit board populated with all components, is shown in Figure 8. The PC board dimensions are 10 cm × 12 cm. In order to capture quantitatively VOCs spanning a wide range in vapor pressure and to thermally desorb them efficiently for separation, as well as to reduce water vapor uptake, the 3-stage µPCF is packed with two hydrophobic graphitized-carbon adsorbents Carbopack B (1st stage: 4270 × 2785 × 380 μm) and Carbopack X (2nd stage: 2405 × 2780 × 380 μm), and a hydrophobic carbon molecular sieve Carboxen 1018 (3rd stage: 1615 × 2779 × 380 μm). The two 3-m-long DRIE-Si/glass microcolumns have cross-sections of 150 × 240 µm and a 0.15 µm thick wall-coated PDMS stationary phase. The columns have on-board heaters and RTDs for temperature programming of
130
the separations. The MPN-coated CR array is mounted on the TE cooler assembly through a cut-out in the PC board. The system also uses heated MEMS interconnects which accommodate fused-silica capillaries to reduce possible adsorptive losses to surfaces of the transfer lines. Commercial valves are used as well as a commercial mini-pump to direct flow. A control program in Labview is being written to be used with a PC-installed 16-bit DAQ card to operate all the components and to process the signals from CR array.
Figure 8. The SPIRON µGC. ACKNOWLEDGMENTS
The authors wish to thank Katharine Beach for microcolumn fabrication, Brendan Casey for wire bonding, Robert Gordenker for PC board design and system integration, and Dr. Qiongyan Zhong for the data in Figure 7. This work was supported by the National Science Foundation Engineering Research Centers Program under Award ERC-9986866, by a Pilot Project Research Grant from the National Institute for Occupational Safety and Health, and by a grant from Intel Corporation.
REFERENCES: [1] D. Poli, P. Carbognani, M. Corradi, M. Goldoni, O.
Acampa, B. Balbi, L. Bianchi, M. Rusca, A. Mutti, "Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study," Respiratory Research, vol. 6(71), pp. 1-10, 2005.
[2] M. Phillips, K. Gleeson, J. M. B. Hughes, J. Greenberg, R. N. Cataneo, L. Baker, W. P. Mcvay, “Volatile organic compounds in breath as markers of
lung cancer: a cross-sectional study”, Lancet, vol. 353, pp. 1930-1933, 1999.
[3] M. Phillips, R. N. Cataneo, R. Condos, G. A. R. Erickson, J. Greenberg, V. L. Bombardi, M. I. Munawar, O. Tietje, “Volatile Biomarkers of Pulmonary Tuberculosis in the Breath,” Tuberculosis, vol. 87, pp. 44-52, 2007.
[4] L. Dominioni, A. Imperatori, F. Rovera, A. Ochetti, G. Torrigiotti, M. Paolucci, “Stage I nonsmall cell lung carcinoma: analysis of survival and implications for screening.” Cancer, vol. 89 pp. 2334-2344, 2000.
[5] World Health Organization, Tuberculosis, the worsening epidemic. 2007.
[6] M. Phillips, J. Herrera, S. Krishnan, M. Zain, J. Greenberg , R. N. Cataneo, “Variation in volatile organic compounds in the breath of normal humans”, Journal of Chromatography B: Biomedical Sciences and Applications, vol. 729(1-2), pp. 75-88, 1999.
[7] D. E. Austin, Y. Peng, B. J. Hansen, I. W. Miller, A. L. Rockwood, A. R. Hawkins, S. E. Tolley, “Novel Ion Traps Using Planar Resistive Electrodes: Implications for Miniaturized Mass Analyzers”, J Am Soc Mass Spectrom, vol. 19, 1435–1441, 2008.
[8] M. A. Skinner, HAPSITE® Gas chromatograph/Mass Spectrometer (GC/MS) Variability Assessment, Bethesda, 2004.
[9] E. Wapelhorst, J.-P. Hauschild, J. Muller, “Complex MEMS: a fully integrated TOF micro mass spectrometer”, Sensors and Actuators A, vol. 138, pp. 22–27, 2007.
[10] E. Sokol, K. E. Edwards, K. Qian, R. G. Cooks, “Rapid hydrocarbon analysis using a miniature rectilinear ion trap mass spectrometer”, Analyst, vol. 133, pp. 1064–1071, 2008.
[11] C. J. Lu, W. Steinecker, W. C. Tian, M. Oborny, J. Nichols, M. Agah, J. Potkay, H. Chan, J. Driscoll, R. D. Sacks, K. Wise, S. Pang, E. T. Zellers, “First-Generation Hybrid MEMS Gas Chromatograph”, Lab-on-a-Chip, vol. 5, pp. 1123–1131, 2005.
[12] S. Reidy, D. George, M. Agah, R. Sacks, “Temperature-programmed GC using silicon microfabricated columns with integrated heaters and temperature sensors”, Anal. Chem., vol. 79, pp. 2911-2917, 2007.
[13] Q. Zhong, W. Steinecker, E. T. Zellers, “Characterization of a High-Performance Portable GC with a Chemiresistor Array Detector,” Analyst, 134, pp. 283-293, 2009.
CONTACT * E.T. Zellers, tel: +1-734-936-0766; [email protected]
131